|
Nanogen, AVANT Rise on Attack Fears |
|
|
|
NEW YORK (Reuters) Shares of Nanogen Inc. and AVANT
Immunotherapeutics Inc., two firms that could be enlisted to detect
biological attacks and treat its victims, soared on Wednesday as U.S.
fears of a biochemical attack were fueled by recent anthrax cases in
Florida.
Several firms specializing in vaccines and diagnostic detection
systems have seen hefty boosts in share prices since the Sept. 11
attacks. But many of these stocks began to give back some of their
gains in Wednesday trading.
|
